162 related articles for article (PubMed ID: 32087404)
21. Knowledge and Acceptability of Long-Acting Reversible Contraception Among Adolescent Women Receiving School-Based Primary Care Services.
Hoopes AJ; Ahrens KR; Gilmore K; Cady J; Haaland WL; Amies Oelschlager AM; Prager S
J Prim Care Community Health; 2016 Jul; 7(3):165-70. PubMed ID: 27067583
[TBL] [Abstract][Full Text] [Related]
22. Attendance of an Initial Follow-up Visit after Long-Acting Reversible Contraception Insertion and Method Continuation Among Adolescents and Young Adults: A Retrospective Study.
Bryson AE; Cabral HJ; Coles MS
J Pediatr Adolesc Gynecol; 2021 Aug; 34(4):525-529. PubMed ID: 33486086
[TBL] [Abstract][Full Text] [Related]
23. Effect of staff training and cost support on provision of long-acting reversible contraception in community health centers.
Buckel C; Maddipati R; Goodman M; Peipert JF; Madden T
Contraception; 2019 Apr; 99(4):222-227. PubMed ID: 30685287
[TBL] [Abstract][Full Text] [Related]
24. Influences on Intentions to Place Long-Acting Reversible Contraceptives: A Pilot Study Comparing According to Provider Specialty in Ohio.
Thompson CM; Broecker J; Dade M; Nottingham K
J Pediatr Adolesc Gynecol; 2018 Oct; 31(5):509-515. PubMed ID: 29580916
[TBL] [Abstract][Full Text] [Related]
25. Can Pediatricians Provide Long-Acting Reversible Contraception?
Norris AH; Pritt NM; Berlan ED
J Pediatr Adolesc Gynecol; 2019 Feb; 32(1):39-43. PubMed ID: 30278228
[TBL] [Abstract][Full Text] [Related]
26. New york city physicians' views of providing long-acting reversible contraception to adolescents.
Rubin SE; Davis K; McKee MD
Ann Fam Med; 2013; 11(2):130-6. PubMed ID: 23508599
[TBL] [Abstract][Full Text] [Related]
27. Postpartum LARC discontinuation and short interval pregnancies among women with HIV: a retrospective 9-year cohort study in South Carolina.
Lazenby G; Francis E; Brzozowski N; Rucker L; Dempsey A
Contraception; 2019 Oct; 100(4):279-282. PubMed ID: 31226321
[TBL] [Abstract][Full Text] [Related]
28. Postabortion Initiation of Long-Acting Reversible Contraception by Adolescent and Nulliparous Women in New Zealand.
Rose SB; Garrett SM
J Adolesc Health; 2016 Feb; 58(2):160-6. PubMed ID: 26603946
[TBL] [Abstract][Full Text] [Related]
29. Promotion of Long-Acting Reversible Contraception Among Adolescents and Young Adults.
Santibenchakul S; Tschann M; Carlson ADP; L Hurwitz E; Salcedo J
J Midwifery Womens Health; 2019 Mar; 64(2):194-200. PubMed ID: 30570219
[TBL] [Abstract][Full Text] [Related]
30. Cost Sharing and Utilization of Postpartum Intrauterine Devices and Contraceptive Implants Among Commercially Insured Women.
Moniz MH; Soliman AB; Kolenic GE; Tilea A; Fendrick AM; Bell S; Dalton VK
Womens Health Issues; 2019; 29(6):465-470. PubMed ID: 31495642
[TBL] [Abstract][Full Text] [Related]
31. Obstetrics-gynecology resident long-acting reversible contraception training: the role of resident and program characteristics.
Maples JM; Espey E; Evans ML; Breeze JL; Ogburn T; Zite NB
Am J Obstet Gynecol; 2020 Apr; 222(4S):S923.e1-S923.e8. PubMed ID: 31866517
[TBL] [Abstract][Full Text] [Related]
32. Differences in Women Who Choose Subdermal Implants Versus Intrauterine Devices.
Lam VC; Hadley EE; Berenson AB; Hirth JM; Jennings K; Patel PR
J Reprod Med; 2016; 61(11-12):529-33. PubMed ID: 30226692
[TBL] [Abstract][Full Text] [Related]
33. Single-visit insertion of long-acting reversible contraception in a single health system.
Stuart GS; Yates L; Crump J; Allison BA; Navarro AL; Tadikonda A; Neal-Perry G; Arora KS
Contraception; 2023 Jul; 123():110009. PubMed ID: 36931546
[TBL] [Abstract][Full Text] [Related]
34. Provider and Health System Factors Associated with Usage of Long-Acting Reversible Contraception in Adolescents.
Smith AJB; Harney KF; Singh T; Hurwitz AG
J Pediatr Adolesc Gynecol; 2017 Dec; 30(6):609-614. PubMed ID: 28502827
[TBL] [Abstract][Full Text] [Related]
35. Temporal Trends in the Uptake and Continuation of the Etonogestrel Implant in a Large Private Practice Setting.
Howard DL; Ford A; Ceballos S; Volker KW
J Womens Health (Larchmt); 2018 Feb; 27(2):191-195. PubMed ID: 28976797
[TBL] [Abstract][Full Text] [Related]
36. Prevalence and associations of prescribing of long-acting reversible contraception by general practitioner registrars: a secondary analysis of ReCEnT data.
Turner R; Tapley A; Sweeney S; Davey A; Holliday E; van Driel M; Henderson K; Ball J; Morgan S; Spike N; FitzGerald K; Magin P
BMJ Sex Reprod Health; 2020 Jul; 46(3):218-225. PubMed ID: 31964777
[TBL] [Abstract][Full Text] [Related]
37. Barriers and Solutions to Improve Adolescent Intrauterine Device Access.
Espey E; Yoder K; Hofler L
J Pediatr Adolesc Gynecol; 2019 Sep; 32(5S):S7-S13. PubMed ID: 31585618
[TBL] [Abstract][Full Text] [Related]
38. Initiation and continuation of long-acting reversible contraception in the United States military healthcare system.
Chiles DP; Roberts TA; Klein DA
Am J Obstet Gynecol; 2016 Sep; 215(3):328.e1-9. PubMed ID: 27005514
[TBL] [Abstract][Full Text] [Related]
39. Facilitators and Barriers to Implementation of Long-Acting Reversible Contraceptive Services for Adolescent Girls and Young Women in Gaborone, Botswana.
Henry D; Wood S; Moshashane N; Ramontshonyana K; Amutah C; Maleki P; Howlett C; Brooks MJ; Mussa A; Joel D; Steenhoff AP; Akers AY; Morroni C
J Pediatr Adolesc Gynecol; 2021 Aug; 34(4):504-513. PubMed ID: 33766793
[TBL] [Abstract][Full Text] [Related]
40. Predictors of Discontinuation of Long-Acting Reversible Contraception Before 30 Months of Use by Adolescents and Young Women.
Cohen R; Sheeder J; Teal SB
J Adolesc Health; 2019 Aug; 65(2):295-302. PubMed ID: 31196778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
